Navigation Links
Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
Date:10/30/2007

LONDON, Oct. 30 /PRNewswire/ -- Chiltern, a leading global clinical research organization (CRO), today announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States. From February 2008 the combined operation will be known exclusively as 'Chiltern'.

Established in 1989 by Dr. Robert Vann, John Vann and Ben Essary, CTMS has extensive experience conducting clinical trials in a wide variety of therapeutic areas with an emphasis on respiratory, gastrointestinal, central nervous system, infectious disease and ophthalmology indications. The company employs 190 people located in offices in Bristol and Winston-Salem, NC. John Vann, previously President and CEO of CTMS, today assumes overall leadership of Chiltern's U.S. operations, becoming Executive Vice-President Americas. Dr Robert Vann retires after a long and successful career in clinical research.

"We are looking forward to bringing together the complementary strengths and resources of Chiltern and CTMS," said Glenn Kerkhof, Chiltern's Chief Executive Officer. "The acquisition of CTMS significantly increases our presence and expertise within the US and strengthens Chiltern's position as a global CRO. CTMS and Chiltern have compatible cultures and are equally focused on delivering high quality services to the pharmaceutical, device and biotech industries. Detailed planning for the integration of our operations is underway and we are very confident of a smooth transition for customers, suppliers and employees alike."

"We are delighted to have found in Chiltern a buyer that not only shares our commitment to excellence in clinical research and service delivery to clients, but also provides our employees with opportunities for growth and participation internationally," said John Vann. "We have been struck throughout by the compatible nature of our organizations and the essentially seamless way we can bring them together. We are excited by the quality, depth and range of services we will be bringing our clients and are proud to be part of the expanded Chiltern team."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1100 people with 20 offices across the United States, Europe and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

For More Information Contact:

Catherine Lemercier Richard Baptista

Chiltern International, Inc. Chiltern International Ltd.

2111 Palomar Airport Road 171 Bath Road

Suite 200 Slough

Carlsbad Berkshire

CA 92011 SL1 4AA

USA UNITED KINGDOM

Tel: 1 (760) 707 5025 Tel: 44 (0) 1753 512 000

Fax: 1 (760) 707 5022 Fax: 44 (0) 1753 511 116

Email: Catherine.Lemercier@chiltern.com Email:

Richard.Baptista@chiltern.com

Chiltern: Understanding Development


'/>"/>
SOURCE Chiltern
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... Plains, NY (PRWEB) , ... April 22, 2017 ... ... Report, which shows that U.S. consumers can save an average of 70% when ... greater savings (up to 97%) are available when purchasing from other countries. The ...
(Date:4/22/2017)... ... ... San Juan Capistrano summer camp team at the Boys and Girls Club of South ... provide physical activities for all campers. To read the report, click here or ... in specialty camps that focus on what the report terms as “sitting subjects” like coding ...
(Date:4/21/2017)... ... , ... Providing broad access to life-saving drugs and rewarding the innovators who ... to address this problem. , That was the message from Dana Goldman, PhD, Leonard ... University of Southern California, who served as the keynote speaker for Western University of ...
(Date:4/21/2017)... ... 2017 , ... Contrary to popular perception, a new study ... noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a 29% ... United States. The study, Trends in Fighting and Violence Among Adolescents in ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
Breaking Medicine Technology: